AIRAscore

by AIRAmed GmbH  · Based in Germany → — Enables enhanced diagnostic accuracy, individual therapies and improved future medical care.
Neurology Radiology

Per-study pricing
Regulatory Status Disclosed

Overview

AIRAscore by AIRAmed is an AI-powered medical image management and processing tool designed for quantitative brain volumetry. The software utilizes deep learning algorithms to analyze brain MRI scans, providing precise measurements of brain structures to assist in the early detection and differential diagnosis of neurodegenerative diseases and movement disorders, such as Alzheimer’s disease, frontotemporal dementia, and multiple sclerosis.

The tool is primarily developed for radiologists, neurologists, and psychiatrists practicing in hospitals, imaging centers, and outpatient neurology clinics. By automating the measurement of brain volume, it helps clinicians distinguish between pathological brain volume loss and age-appropriate changes.

In a clinical workflow, the process begins when a patient undergoes a standard brain MRI. The scanned images are securely transmitted for analysis, and AIRAscore processes the data in approximately five minutes. It delivers a standardized, objective evaluation report directly to the clinical team. This report compares the patient’s brain volume against a large, age- and sex-matched reference population, accounting for head size.

Notable capabilities of AIRAscore include:

  • Automated segmentation of gray matter, white matter, cerebrospinal fluid (CSF), and T1 hypointensities.
  • Detailed regional measurements of specific brain areas, including the brain lobes, cerebellum, hippocampus, ventricles, pons, and midbrain.
  • Visual and narrative reporting, presenting data in both pictographic and quantitative formats to support longitudinal tracking and clinical decision-making.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered brain volumetry from MRI scans
  • Objective measurement values for dedicated brain areas
  • Comparison with a large reference population (age, gender, head size corrected)
  • Detailed evaluation reports with precise measurement results
  • Auto segmentation of grey matter, white matter, cerebrospinal fluid, and T1 hyperintensities
  • Measurements of all brain lobes, midbrain and pons, hippocampus, cerebellum, and ventricular systems
  • Rapid analysis and evaluation report within minutes (as little as five minutes)
  • Pseudonymized data transmission for maximum data protection
  • Easy integration and quick installation (less than an hour)

Use Cases

  • Early detection of neurodegenerative diseases (e.g., Alzheimer's, Parkinson's, Multiple Sclerosis)
  • Differential diagnosis of dementias and movement disorders
  • Monitoring disease progression and treatment effectiveness
  • Supplementing visual diagnosis with objective data
  • Risk assessment for conversion to dementia for patients with mild cognitive impairment
  • Improved clinical reporting

What Physicians Need to Know

Brain MRI/CT Analysis
AIRAscore is an AI-powered software that analyzes MRI brain scans to provide quantitative brain volume data. It performs auto-segmentation of grey matter, white matter, cerebrospinal fluid, and T1 hyperintensities, offering detailed measurements of all brain lobes, midbrain and pons, hippocampus, cerebellum, and ventricular systems. This allows clinicians to objectively assess MRI brain scans and compare them with a large, age- and gender-specific reference population, helping to identify brain volumes that are not age-appropriate. The software provides results in narrative and pictographic form, including tabular reports with bar graphs.
Neurodegenerative Disease Screening
AIRAscore is designed to assist in the early detection and differential diagnosis of Alzheimer's disease (AD) and other related dementias, such as frontotemporal dementia, by quantifying brain atrophy and other markers. It can detect subtle brain volume loss early in the disease course that might not be observable with the human eye. The tool also supports monitoring neurodegeneration over time during therapy to assess treatment effectiveness.
Triage Prioritization Speed
AIRAscore can provide quantitative brain volume data from MRI scans in as little as five minutes. This rapid analysis can significantly improve workflow efficiency in diagnosing neurodegenerative diseases.
Physician Tip

AIRAscore offers objective and quantitative data to support the diagnosis and treatment of neurodegenerative diseases, complementing visual assessments. It can help differentiate between various dementia forms and movement disorders by identifying brain volumes that deviate from age-appropriate norms. The software's ability to monitor brain volume changes over time is valuable for tracking disease progression and adjusting therapies. It can also be used for screening and reassuring patients concerned about neurodegenerative diseases.

AIRAscore is a software as a medical device (SaMD) that runs on internal servers as a Software as a Service (SaaS). It is designed for integration into standard reading environments, such as Picture Archiving and Communication Systems (PACS). The software is relatively low-cost and can be configured by a hospital's or radiology facility's IT department in less than an hour. It uses DICOM compliant input of T1-weighted and optionally FLAIR MR images. The output includes volumetric reports and annotated DICOM images. Deployment options include cloud-based, hybrid, or locally virtualized solutions (virtual machine, Docker).

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Per-study pricing
DeploymentSoftware as a Service (SaaS) running on internal servers. Can be configured by a hospital's or radiology facility's IT department.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
GDPR Yes AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AIRAscore

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for AIRAscore.

Loading videos...

View all on YouTube

Frequently Asked Questions

AIRAscore is an AI-powered software that analyzes brain MRI scans to quantify brain volume and detect subtle volume loss associated with neurodegenerative diseases like Alzheimer's and other dementias. It provides neurologists with objective, quantitative data to aid in earlier detection, differential diagnosis, and monitoring disease progression, offering a standardized view that complements visual assessment.
AIRAscore processes standard brain MRI scans, automatically segmenting brain regions like gray matter, white matter, and limbic structures. It then measures their volumes and compares them to a large reference population, adjusted for age, sex, and head size. This helps neurologists identify brain volumes that are not age-appropriate, aiding in the diagnosis and differentiation of various dementias and movement disorders.
AIRAscore has received FDA 510(k) clearance in the U.S. and is a CE-marked medical device under MDR in Europe, indicating it meets regulatory standards for medical devices. Data transfer is pseudonymized and encrypted, with only image data, age, and sex sent for analysis, addressing data privacy concerns.
Yes, several AI tools exist in neurology. Some focus on neuroimaging like Viz.ai and RapidAI for stroke detection, while others provide clinical decision support such as EvidenceMD, ClinicalKey AI, MedLink AI, and Vera Health, which assist with complex differentials, treatment planning, and workflow efficiency.
AIRAscore is described as 'extremely affordable' and can be configured by a hospital's or radiology facility's IT department in less than an hour. It is often billed as a private service, allowing physicians to decide case-by-case, with no fixed contract terms. Practices can also try AIRAscore with up to 10 analyses for free over four weeks.
While AIRAscore provides precise quantitative data, it is a tool to assist diagnosis and not a standalone diagnostic. It complements the physician's visual assessment and clinical judgment. AI tools in general also face challenges regarding data privacy, potential biases in algorithms, and the need for continuous research to refine accuracy and reliability.
After an MRI scan, the images are automatically measured by AIRAscore, and a report with all measurements is typically available to the radiologist within a few minutes. The analysis starts automatically once the images arrive, and the report can be integrated into the PACS.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-10-14 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.